The Motley Fool·Feb 19·Scott LevineTrilogy Metals Shares Plummet Amid Full-Year Loss and Major Investor ExitTrilogy Metals shares tumbled after reporting a $42.2 million full-year loss and major investor Paulson & Co. exiting its position entirely. TMQstock declineQ4 2025 earnings
GlobeNewswire Inc.·Feb 17·NaDaily Journal Posts Q1 Revenue Gains Despite Investment LossesDaily Journal's Q1 revenue grew 10% to $19.5M, but a $8M net loss resulted from $11.7M in investment portfolio losses, offsetting operational gains. DJCOnet lossrevenue growth
The Motley Fool·Feb 16·Adé HennisSnap CTO Divests $10.6M in Shares as Stock Hits Historic LowSnap's CTO sold $10.6M in shares as stock hits all-time low of $4.72, amid weak revenue guidance and continued losses in competitive ad market. METASNAPstock declinenet loss
The Motley Fool·Feb 13·Neha ChamariaCleveland-Cliffs Shares Tumble 32.5% on Substantial 2025 Loss Amid Sector HeadwindsCleveland-Cliffs shares plunged 32.5% after reporting $1.4 billion loss in 2025, hit by weak auto demand and unprofitable steel deal. Management expects 2026 recovery. CLFMTearnings missnet loss
Benzinga·Feb 13·PrnewswireCitius Oncology Posts Maiden Revenue of $3.9M From LYMPHIR LaunchCitius Oncology reports maiden revenue of $3.9M from LYMPHIR immunotherapy launch in December 2025, marking transition to commercial-stage biopharmaceutical company. CTXRCTORnet lossFDA approval